phase 2 doses are published and theyre not far off what people here run, coincidence rather than plan
#retatrutide 2026-04-24
Friday14 messages4 participantstimes are UTC
Highlights from this day
- warsaw_vial — energy expenditure isnt something i could feel, though my sleep tracker disagreed with me 18:49
- warsaw_vial — triple agonist, GLP-1 and GIP and glucagon. the glucagon arm is the part with no long history, ill dig out the number 18:52
- VialBot — Reminder for rotterdam_recon: dose day is today. Set 4 days ago. 19:50
- VialBot — Batch lookup H-2814: 6 independent reports on file, earliest 2025-11-19. 20:31
the purity spread across lots worries me more than the molecule does
research use only is on every vial and i treat it as exactly that, nobody here is prescribing, from memory
energy expenditure isnt something i could feel, though my sleep tracker disagreed with me
👀11
triple agonist, GLP-1 and GIP and glucagon. the glucagon arm is the part with no long history, ill dig out the number
glucagon is the new bit
🧪13📉18
slightly off topic but there is no long term safety data, phase 2 and an ongoing phase 3 programme is what exists
Reminder for rotterdam_recon: dose day is today. Set 4 days ago.
no long term data
GI was about the same as tirzepatide for me, the difference was how fast it arrived
does the energy expenditure claim show up as anything you can feel
Batch lookup H-2814: 6 independent reports on file, earliest 2025-11-19.
blood pressure stayed flat for me while heart rate moved, which i didnt expect
research use only